Medical Device News Magazine

Despite Fears to the Contrary, Canadian Wildfire Smoke Exposure Was Not Much Worse Than A Bad Pollen Day in New York City

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

New Yorkers can apparently breathe a sigh of relief, at least for now. Their exposure to the smoke in June 2023 from Canadian wildfires led to only a slightly higher bump in visits to New York City hospital emergency departments for breathing problems or asthma attacks than what is seen on days when pollen counts are high. However, authors of a new study say other possible health effects, such as possible heart attacks and stroke, still need to be investigated.

For the study, researchers at NYU Grossman School of Medicine analyzed daily levels of air pollution, as measured by the presence of tiny particles known as particulate matter 2.5, which can if lodged deep in the lungs lead to inflammation, as well as respiratory and heart problems.

When researchers assessed air pollution levels for the first six months of 2023, including months of regular ambient (or general background) air pollution and the days in June when wildfire smoke peaked, they found that wildfire smoke led to a 3% average increase in asthma-related visits to emergency departments across all city hospitals (for every 10 microgram increase in PM 2.5 per cubic meter of air).

When wildfire smoke was at its worst on June 7, 2023 (at a PM 2.5 of 146 micrograms per cubic meter of air), citywide asthma-related emergency visits peaked at 335, up from a daily average of 188 per day earlier in the year, when the skies were clear of wildfire smoke.

By comparison, they say this peak wildfire number is only slightly higher than the 302 asthma-related emergencies seen on April 26, 2023, when the level of tree pollen, another lung irritant and known asthma trigger, was high (at tree pollen counts above 1,500 per cubic meter of air).

The researchers caution that while no deaths tied to the wildfire smoke were reported in June, asthma remains a serious and potentially life-threatening lung disease.

“Thankfully, the respiratory effects of the wildfire smoke in June were not much worse than what had been seen on really bad pollen days back in the spring, and despite what many New Yorkers may have feared on seeing hazy, orange air,” said study co-investigator Wuyue Yu, a doctoral student at NYU Langone Health.

Yu says the latest findings, published in the American Journal of Respiratory and Critical Care Medicine online Aug. 15, mirror those seen with increases in ambient air pollution and pollen seen elsewhere, and their effects on asthma-related hospital emergencies.

“Still, the long-term consequences, if any, of exposure to wildfire smoke remain unknown, so we are not yet totally in the clear,” said study co-investigator David Luglio, a doctoral student at NYU Langone Health.

Researchers say they already have study plans for further air monitoring and for comparing the health effects of exposure to wildfire smoke to particulate matter more commonly inhaled from fossil-fuel combustion, which is more dangerous.

“While inhaling any particle-filled air is not good for your lungs, we do know that wildfire smoke is primarily made up of organic matter,” said senior study investigator George Thurston, ScD, a professor in the Departments of Medicine and Population Health at NYU Langone. “As a result, it is not enriched in the toxic metals that are found in fossil-fuel emissions, which are known to cause damaging oxidative stress in the body.”

Indeed, Thurston says this was reflected in other study results, which showed that the wildfire smoke contained 64% more potassium than ambient air pollution, with potassium a key component to soil and foliage. By contrast, the wildfire smoke contained just 12% of the average levels of copper present in background air pollution and 26% of the average levels of sulfur observed in the ambient air. Both are found in average New York City air and are known causes of oxidative stress when inhaled.

For the study, which was funded by NYU Langone, researchers used hospital patient data supplied by the New York City Department of Health and Mental Hygiene. Pollution and pollen data was in part supplied by the New York State Department of Environmental Conservation, which maintains multiple air-monitoring stations across the city, and by air sampling performed by the study team.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”